Angiogenesis in hematologic malignancies (Q73119139)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633837%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

review article

1 reference

title

Angiogenesis in hematologic malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633837%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

Moehler TM

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633837%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Ho AD

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633837%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Goldschmidt H

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633837%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Barlogie B

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633837%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633837%20AND%20SRC:MED&resulttype=core&format=json

Critical Reviews in Oncology Hematology

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633837%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633837%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633837%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

227-244

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633837%20AND%20SRC:MED&resulttype=core&format=json

Angiogenesis in cancer and other diseases

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Mechanisms of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Vascular-specific growth factors and blood vessel formation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Role of integrins in angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Halting angiogenesis suppresses carcinoma cell invasion

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Effects of angiogenesis inhibitors on multistage carcinogenesis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Vasculogenic mimicry: how convincing, how novel, and how significant?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Vasculogenic mimicry and tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

The growth of highly proliferative acute lymphoblastic leukemia may be independent of stroma and/or angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Angiogenesis in hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

The thin red line: angiogenesis in normal and malignant hematopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Current status of antiangiogenic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Expression of vascular endothelial growth factor in lymphomas and Castleman's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Angiogenesis and angiogenic mediators in haematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Tie2 ligands angiopoietin-1 and angiopoietin-2 are coexpressed with vascular endothelial cell growth factor in growing human bone

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Angiogenesis and mast cells in non-Hodgkin's lymphoma: a strong correlation in angioimmunoblastic T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Angiogenesis in chronic myeloproliferative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Pieces of eight: bioactive fragments of extracellular proteins as regulators of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Maspin is an angiogenesis inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Soluble VEGFR-1 secreted by endothelial cells and monocytes is present in human serum and plasma from healthy donors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Signal transduction. How do cells sense oxygen?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Reactive oxygen generated by Nox1 triggers the angiogenic switch

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Transforming growth factor-beta and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Angiogenesis is an early event in the generation of myc-induced lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Overexpression of ornithine decarboxylase enhances endothelial proliferation by suppressing endostatin expression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Multiple myeloma with deletion of chromosome 13q is characterized by increased bone marrow neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Enhanced T-lineage acute lymphoblastic leukaemia cell survival on bone marrow stroma requires involvement of LFA-1 and ICAM-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Expression of endothelial cell-associated molecules in AML cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and gamma-irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

CD40 activation induces p53-dependent vascular endothelial growth factor secretion in human multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Matrix metalloproteinases: biologic activity and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Soluble IL-6R alpha upregulated IL-6, MMP-1 and MMP-2 secretion in bone marrow stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

MMP-2 and MMP-9 expression in adult and childhood acute lymphatic leukemia (ALL)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Assessing tumor angiogenesis using macromolecular MR imaging contrast media.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Assessment of tumor microcirculation: a new role of dynamic contrast MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Evaluation of angiogenesis and perfusion of bone marrow lesions: role of semiquantitative and quantitative dynamic MRI

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Endotoxins induce and interferon alpha suppresses vascular endothelial growth factor (VEGF) production in human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Bcl-2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Angiogenesis in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Prognostic evaluation of the microvascular network in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Dynamic MRI of the lumbar spine for the evaluation of microcirculation during anti-angiogenetic therapy in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Angiogenesis in acute and chronic leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Common origins of blood and blood vessels in adults?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Significance of angiogenin plasma concentrations in patients with acute myeloid leukaemia and advanced myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Bone marrow angiogenesis and progression in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Angiogenesis in B-cell chronic lymphocytic leukemia: methods of study, clinical significance and prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Death to a blood vessel, death to a tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Endostatin induces endothelial cell apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Combined effects of angiostatin and ionizing radiation in antitumour therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Oral idarubicin in patients with late chronic phase chronic myelogenous leukemia or chronic myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Thalidomide is an inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Response to thalidomide in progressive multiple myeloma is not mediated by inhibition of angiogenic cytokine secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Antitumor activity of thalidomide in refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Efficacy and safety of thalidomide in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Antiangiogenesis -- therapeutic strategies and clinical implications for brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

The antiproliferative effect of interferon and the mitogenic activity of growth factors are independent cell cycle events. Studies with vascular smooth muscle cells and endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Successful treatment of infantile hemangiomas with interferon-alpha-2b

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Metronomic scheduling: the future of chemotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Molecular mechanisms of lymphangiogenesis in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Looking for a good endothelial address

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

Effect of p53 status on tumor response to antiangiogenic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

TNP-470 and recombinant human interferon-alpha2a inhibit angiogenesis synergistically

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900135-X

7 January 2021

10.1016/S1040-8428(02)00135-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633837%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference